Antiepileptic drugs are medications that reduce neuronal excitability and abnormal synchronous firing in the brain, providing seizure control for patients with epilepsy and related conditions. They achieve this through diverse mechanisms including sodium channel blockade, GABA enhancement, and calcium channel modulation, allowing individualized therapy based on seizure type and patient factors.
What Are Antiepileptic Drugs?
Epilepsy is a neurological disorder characterized by recurrent unprovoked seizures resulting from abnormal electrical activity in the brain. Antiepileptic drugs do not cure epilepsy but suppress seizure activity through maintenance of neuronal membrane stability, enhancement of inhibitory neurotransmission, or reduction of excitatory neurotransmission. Approximately two-thirds of patients achieve seizure freedom with appropriately selected antiepileptic drug therapy.
Mechanism of Action
Sodium channel blockers such as phenytoin, carbamazepine, and lamotrigine stabilize the inactive state of voltage-gated sodium channels, prolonging the refractory period and preventing high-frequency neuronal firing. Phenytoin exhibits saturation kinetics, meaning small dose increases can cause disproportionate rises in serum concentration, requiring careful therapeutic drug monitoring. Carbamazepine is a potent enzyme inducer that accelerates metabolism of many other drugs.
GABA enhancers increase inhibitory neurotransmission through various mechanisms. Benzodiazepines and barbiturates potentiate GABA-A receptor activity. Tiagabine inhibits GABA reuptake into neurons and glia. Vigabatrin irreversibly inhibits GABA transaminase, the enzyme that breaks down GABA. Valproate increases GABA synthesis and has additional mechanisms including sodium channel blockade and T-type calcium channel inhibition.
Calcium channel modulators include ethosuximide, which blocks T-type calcium channels in thalamic neurons, making it a first-line agent for childhood absence epilepsy. Gabapentin and pregabalin bind to the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and neurotransmitter release. These agents are also effective for neuropathic pain and generalized anxiety disorder.
Newer antiepileptic drugs such as levetiracetam bind to synaptic vesicle protein 2A, modulating neurotransmitter release through a unique mechanism that provides broad-spectrum efficacy with minimal drug interactions.
Therapeutic Uses
Antiepileptic drugs are classified as narrow-spectrum, effective for specific seizure types, or broad-spectrum, effective across multiple seizure types. Focal seizures are typically treated with carbamazepine, lamotrigine, or levetiracetam. Generalized tonic-clonic seizures respond to valproate, lamotrigine, or levetiracetam. Absence seizures are treated with ethosuximide or valproate. Many antiepileptic drugs are also used for non-epileptic conditions including neuropathic pain, migraine prophylaxis, and bipolar disorder.
Adverse Effects
Adverse effects vary by drug. Common dose-related effects include sedation, dizziness, ataxia, and diplopia. Idiosyncratic reactions include rash, which can progress to Stevens-Johnson syndrome with carbamazepine, lamotrigine, and phenytoin. Valproate causes hepatotoxicity, thrombocytopenia, and teratogenicity, including neural tube defects. Chronic phenytoin use causes gingival hyperplasia, hirsutism, and cerebellar atrophy. Levetiracetam is associated with behavioral and psychiatric effects including irritability and psychosis.
Contraindications
Pregnancy is a significant consideration, as many antiepileptic drugs are teratogenic, with valproate carrying the highest risk. Drug interactions are common, particularly with enzyme-inducing antiepileptic drugs that reduce the efficacy of oral contraceptives, anticoagulants, and many other medications.
Conclusion
The diverse mechanisms of antiepileptic drugs provide options for individualized therapy based on seizure type, patient age, comorbidities, and potential drug interactions. Selection of the most appropriate agent requires balancing efficacy against adverse effect profiles and teratogenic risks.
